BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15032645)

  • 1. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases.
    Mizuno M; Morgan BP
    Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):87-96. PubMed ID: 15032645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting complement in therapy.
    Kirschfink M
    Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling the complement system in inflammation.
    Kirschfink M
    Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of current knowledge of the complement system and the therapeutic opportunities in inflammatory arthritis.
    Mizuno M
    Curr Med Chem; 2006; 13(14):1707-17. PubMed ID: 16787214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics.
    Sahu A; Lambris JD
    Immunopharmacology; 2000 Aug; 49(1-2):133-48. PubMed ID: 10904113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical applications of recombinant complement inhibitors].
    Lipiński D; Pławski A; Juzwa W; Zeyland J; Słomski R
    Pol Merkur Lekarski; 2004 Jun; 16(96):571-5. PubMed ID: 15510900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C5a regulators in inflammatory disease.
    Mizuno M; Cole DS
    Expert Opin Investig Drugs; 2005 Jul; 14(7):807-21. PubMed ID: 16022570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The complement system: an old story or target of new therapeutic approaches?].
    Heller A; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.
    Gasque P; Neal JW; Singhrao SK; McGreal EP; Dean YD; Van BJ; Morgan BP
    Mol Neurobiol; 2002 Feb; 25(1):1-17. PubMed ID: 11890454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and autoimmune glomerular diseases.
    Quigg RJ
    Curr Dir Autoimmun; 2004; 7():165-80. PubMed ID: 14719380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of complement inhibitors in myocardial ischaemia.
    Lucchesi BR; Tanhehco EJ
    Expert Opin Investig Drugs; 2000 May; 9(5):975-91. PubMed ID: 11060721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological manipulation of the complement system in human diseases.
    Asghar SS
    Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement.
    Monsinjon T; Richard V; Fontaine M
    Fundam Clin Pharmacol; 2001 Oct; 15(5):293-306. PubMed ID: 11903498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy].
    Kirschfink M
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1087-90. PubMed ID: 7641591
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement therapeutics; history and current progress.
    Morgan BP; Harris CL
    Mol Immunol; 2003 Sep; 40(2-4):159-70. PubMed ID: 12914822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring anti-complement therapeutics.
    Harris CL; Fraser DA; Morgan BP
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1019-26. PubMed ID: 12440965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.
    Heesterbeek DAC; Angelier ML; Harrison RA; Rooijakkers SHM
    J Innate Immun; 2018; 10(5-6):455-464. PubMed ID: 30149378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.